Exane Derivatives Hercules Capital, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Hercules Capital, Inc. stock. As of the latest transaction made, Exane Derivatives holds 3,094 shares of HTGC stock, worth $60,611. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,094
Previous 3,094
-0.0%
Holding current value
$60,611
Previous $55,000
25.45%
% of portfolio
0.03%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding HTGC
# of Institutions
327Shares Held
32.8MCall Options Held
711KPut Options Held
838K-
Van Eck Associates Corp3.12MShares$61 Million0.08% of portfolio
-
Sound Income Strategies, LLC2.74MShares$53.6 Million3.83% of portfolio
-
Morgan Stanley New York, NY1.26MShares$24.6 Million0.0% of portfolio
-
Legal & General Group PLC London, X01.17MShares$23 Million0.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC987KShares$19.3 Million0.01% of portfolio
About Hercules Capital, Inc.
- Ticker HTGC
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Shares Outstandng 127,239,000
- Market Cap $2.49B
- Description
- Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower...